Comparing Extracorporeal Shockwave and Pulsed Electromagnetic Field Therapies Combined with Pelvic Floor Muscle Training in Women with Sexual Dysfunction

What this Trial Is About

Researchers are evaluating treatments for female sexual dysfunction FSD, a condition involving physical and psychological factors that affect sexual function, including pelvic floor issues and blood flow problems. This trial compares three approaches extracorporeal shockwave therapy ESWT combined with pelvic floor muscle training PFMT, pulsed electromagnetic field stimulation PEMF combined with PFMT, and PFMT alone. The goal is to see which method improves sexual function in women with FSD. The study design is a randomized controlled trial with assessor blinding to reduce bias. Ninety women with FSD will be randomly assigned to one of three groups. The ESWT group will receive weekly low-intensity shockwave therapy sessions targeting the pelvic floor for eight weeks, along with supervised PFMT three times per week. The PEMF group will have pulsed electromagnetic stimulation three times weekly for eight weeks plus the same PFMT program. The control group will perform only the supervised PFMT. The PFMT involves exercises done three times weekly, focusing on contracting pelvic floor muscles under guidance, with additional home exercises. Participants will be assessed at the start, after eight weeks of treatment, and at sixteen weeks, including follow-up. Researchers will measure sexual function using the Female Sexual Function Index FSFI total score, sexual quality of life, and pelvic floor muscle strength. Assessments will include questionnaires and muscle strength tests. The study lasts sixteen weeks in total, with eight weeks of intervention and eight weeks of follow-up, to monitor changes and treatment effects while ensuring safety and adherence.

Effects of Extracorporeal Shockwave Therapy Versus Pulsed Electromagnetic Field Therapy in Females With Sexual Dysfunction.